Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Little sedi action.

<< Previous

Bullboard Posts

Next >>

Comment by fox7mfon Feb 27, 2023 8:23pm

126 Views

Post# 35308491

RE:RE:RE:RE:RE:Little sedi action.

This 90 day exclusivity has been burdensome & may amount to squat for Onc. PFE is supposedly going over Bracelet data with a fine tooth comb, yet it's Seagen who's the rumored lottery winner. If they're spending $30b-$40b on Seagen this yr, then maybe just maybe they'll throw enough together for a bs biobucks deal for Onc. When do Oncy investors wake up to a well placed BP acquisition rumor on Bloomberg or wtv. My sentiment on a buyout has nosedived, and Coffey being seemingly incapable of supporting or increasing the SP isn't helping.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"